Joohyuk Sohn

Joohyuk Sohn

UNVERIFIED PROFILE

Are you Joohyuk Sohn?   Register this Author

Register author
Joohyuk Sohn

Joohyuk Sohn

Publications by authors named "Joohyuk Sohn"

Are you Joohyuk Sohn?   Register this Author

54Publications

1525Reads

24Profile Views

Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older.

Breast Cancer Res Treat 2020 Feb 6;179(3):687-697. Epub 2019 Dec 6.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05505-4DOI Listing
February 2020

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.

N Engl J Med 2020 02 11;382(7):610-621. Epub 2019 Dec 11.

From Memorial Sloan Kettering Cancer Center, New York (S.M.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (C.S., J.C.), and IOB Institute of Oncology, Quiron Group, Barcelona and Madrid (J.C.); Kanagawa Cancer Center, Yokohama (T.Y.), National Cancer Center Hospital (K.T.), the Cancer Institute Hospital of the Japanese Foundation for Cancer Research (Y.I.), and the Advanced Cancer Translational Research Institute, Showa University (J.T.), Tokyo, Aichi Cancer Center Hospital, Nagoya (H.I.), Kindai University Faculty of Medicine, Osaka (J.T.), Shikoku Cancer Center, Matsuyama (K.A.), and the National Hospital Organization Kyushu Cancer Center, Fukuoka (E.T.) - all in Japan; Samsung Medical Center (Y.H.P.), Asan Medical Center, University of Ulsan College of Medicine (S.-B.K.), Yonsei Cancer Center, Yonsei University Health System (J. Sohn), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), Seoul, and the National Cancer Center, Gyeonggi (K.S.L.) - all in South Korea; Institut Gustave Roussy, Université Paris-Sud, Villejuif (F.A.), and Centre Eugène Marquis, Rennes (C.P.) - both in France; the US Oncology Network, Virginia Cancer Specialists, Arlington (N.D.); the University of California, Los Angeles-Jonsson Comprehensive Cancer Center, Los Angeles (S.A.H.); Daiichi Sankyo, Basking Ridge, NJ (C.L., S.C., L.Z., J. Shahidi, A.Y.); and the Dana-Farber Cancer Institute, Boston (I.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1914510DOI Listing
February 2020

Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11).

Breast Cancer Res Treat 2019 Nov 12;178(2):367-377. Epub 2019 Aug 12.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05400-yDOI Listing
November 2019

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review.

Int J Cancer 2019 09 7;145(5):1179-1188. Epub 2019 Jan 7.

Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, South Korea.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.32020
Publisher Site
http://dx.doi.org/10.1002/ijc.32020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767051PMC
September 2019

Effect of primary tumor resection on overall survival in patients with stage IV breast cancer.

Breast J 2019 09 11;25(5):908-915. Epub 2019 Jun 11.

Department of Surgery, Yonsei University College of Medicine, Seodaemoon-gu, 03722, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13344DOI Listing
September 2019

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.

N Engl J Med 2019 07 4;381(4):307-316. Epub 2019 Jun 4.

From Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (S.-A.I.), the Yonsei Cancer Center, Yonsei University Health System (J.S.), and the Asan Medical Center, University of Ulsan College of Medicine (K.-H.J.), Seoul, and the Center for Breast Cancer, National Cancer Center, Gyeonggi-do (K.-S.L.) - all in South Korea; National Taiwan University Hospital, Taipei, Taiwan (Y.-S.L.); Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (A.B.); the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany (N.H.); the Division of Medical Senology, Istituto Europeo di Oncologia, Milan (M.C.); Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil (F.F.); the Organisation for Oncology and Translational Research, Hong Kong (L.C.); Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico (S.C.-G.); Institut Català d'Oncologia, Hospital de Sant Joan Despí Moisès Broggi, Barcelona (R.V.-V.); Novartis Pharmaceuticals, East Hanover, NJ (A.C., K.R.-L., T.T.); Novartis, Basel, Switzerland (G.H., I.G.); the UCLA Jonsson Comprehensive Cancer Center, Los Angeles (S.H.); and the University of Texas M.D. Anderson Cancer Center, Houston (D.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903765DOI Listing
July 2019

The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control.

Cancer Nurs 2018 Mar/Apr;41(2):E49-E57

Author Affiliations: College of Medicine, Yonsei University and Yonsei Cancer Center (Dr Rha, Dr Sohn, Dr HR Kim, and Dr J Kim); Songdang Institute for Cancer Research, Yonsei University College of Medicine (Dr Rha); Brain Korea 21 Project for Medical Sciences (Dr Rha), Seoul; and College of Nursing, Chungnam National University (Dr Lee), Daejeon, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NCC.0000000000000484DOI Listing
April 2019

A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide.

Cancer Res Treat 2019 Apr 19;51(2):812-818. Epub 2018 Sep 19.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473288PMC
April 2019

Cooperative Effect of Oncogenic and in an HGF-Dominant Environment in Breast Cancer.

Mol Cancer Ther 2019 02 5;18(2):399-412. Epub 2018 Dec 5.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0710DOI Listing
February 2019

Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.

Clin Breast Cancer 2018 10 19;18(5):e1165-e1172. Epub 2018 Apr 19.

Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.04.008DOI Listing
October 2018

Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials.

J Glob Oncol 2018 07;4:1-12

Chia-Jui Yen, National Cheng Kung University Hospital, Tainan; Jin-Yuan Shih, National Taiwan University Hospital; Yee Chao, National Yang-Ming University and Taipei Veterans General Hospital; Rebecca Cheng, Eli Lilly and Company, Taipei, Taiwan; Kei Muro, Aichi Cancer Center Hospital, Nagoya; Masatoshi Kudo, Kindai University School of Medicine, Osaka-Sayama City, Osaka; Kentaro Yamazaki, Shizuoka Cancer Center, Shizuoka, Japan; Tae-Won Kim and Sang-We Kim, Asan Medical Center; JooHyuk Sohn and Hyun Cheol Chung, Yonsei University College of Medicine, Seoul; Keun-Wook Lee, Seoul National University College of Medicine, Seongnam, South Korea; Yawei Zhang and Polina Binder, Eli Lilly and Company, Bridgewater, NJ; Gu Mi, Eli Lilly and Company, Indianapolis, IN, USA; and Mauro Orlando, Eli Lilly and Company, Buenos Aires, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223521PMC
July 2018

Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.

Clin Breast Cancer 2018 04 17;18(2):e167-e178. Epub 2017 Jun 17.

Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.06.002DOI Listing
April 2018

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer.

J Clin Oncol 2017 Nov 2;35(32):3638-3646. Epub 2017 Oct 2.

Matthew P. Goetz, Mayo Clinic, Rochester, MN; Masakazu Toi, Kyoto University, Kyoto, Japan; Mario Campone, Institut de Cancerologie de l'Ouest, Angers Cedex; Olivier Trédan, Centre Léon Bérard, Lyon; Nawel Bourayou, Eli Lilly, Paris, France; Joohyuk Sohn, Yonsei Cancer Center, Seoul; In Hae Park, National Cancer Center, Goyangsi, South Korea; Shani Paluch-Shimon, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Jens Huober, University of Ulm, Ulm, Germany; Shin-Cheh Chen, Chang Gung University Medical College, Taipei, Taiwan; Luis Manso, Hospital Universitario 12 de Octubre; Susana Barriga, Eli Lilly, Madrid, Spain; Orit C. Freedman, Durham Regional Cancer Centre, Oshawa, Ontario, Canada; Georgina Garnica Jaliffe, Grupo Médico CAMINO S.C., Mexico City, Mexico; Tammy Forrester, Martin Frenzel, and Ian C. Smith, Eli Lilly, Indianapolis, IN; and Angelo Di Leo, Hospital of Prato, Prato, Italy.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.75.6155
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.75.6155DOI Listing
November 2017

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.

J Clin Oncol 2017 Sep 3;35(25):2875-2884. Epub 2017 Jun 3.

George W. Sledge Jr., Stanford University, Stanford; Han Koh, Kaiser Permanente Medical Group, Bellflower, CA; Masakazu Toi, Kyoto University; Kenichi Inoue, Saitama Cancer Center, Saitama; Norikazu Masuda, Osaka National Hospital, Osaka, Japan; Patrick Neven, Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium; Joohyuk Sohn, Yonsei Cancer Center, Seoul, Korea; Xavier Pivot, CHU de Besancon Hopital Jean Minjoz, Besancon Cedex; Nawel Bourayou, Eli Lilly, Paris, France; Olga Burdaeva, Arkhangelsk Regional Clinical Oncology Dispensary, Arkhangelsk, Russian Federation; Meena Okera, Adelaide Cancer Centre, Adelaide, Australia; Peter A. Kaufman, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Eva-Maria Grischke, Universitätsklinikum Tübingen Frauenklinik, Tübingen, Germany; Martin Frenzel, Yong Lin, and Ian C. Smith, Eli Lilly, Indianapolis, IN; Susana Barriga, Eli Lilly, Madrid; and Antonio Llombart-Cussac, Hospital Arnau Vilanova, Valencia, Spain.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.7585
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.7585DOI Listing
September 2017

Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer.

Breast Cancer Res Treat 2017 Jun 27;163(2):255-262. Epub 2017 Feb 27.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 120-752, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4175-yDOI Listing
June 2017

Chemotherapy-induced irreversible alopecia in early breast cancer patients.

Breast Cancer Res Treat 2017 Jun 21;163(3):527-533. Epub 2017 Mar 21.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4204-xDOI Listing
June 2017

Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.

J Breast Cancer 2016 Mar 25;19(1):76-82. Epub 2016 Mar 25.

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2016.19.1.76DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822110PMC
March 2016

Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.

Int J Clin Oncol 2015 Oct 24;20(5):878-90. Epub 2015 Feb 24.

Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, 1 Yonseidae-gil, Wonju, Gangwon, 220-710, Republic of Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs10147-015-07
Web Search
http://link.springer.com/10.1007/s10147-015-0798-3
Publisher Site
http://dx.doi.org/10.1007/s10147-015-0798-3DOI Listing
October 2015

Prediction of short- and long-term survival for advanced cancer patients after ICU admission.

Support Care Cancer 2015 Jun 23;23(6):1647-55. Epub 2014 Nov 23.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2519-2DOI Listing
June 2015

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer.

J Cancer 2014 15;5(9):745-53. Epub 2014 Oct 15.

1. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ; 3. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.9696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216798PMC
November 2014

Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer.

Breast 2013 Dec 14;22(6):1205-9. Epub 2013 Oct 14.

Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.08.013DOI Listing
December 2013

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.

BMC Cancer 2013 Dec 6;13:583. Epub 2013 Dec 6.

Yonsei Cancer Center, Divison of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029391PMC
December 2013

Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Oncology 2010 23;79(5-6):324-30. Epub 2011 Mar 23.

Department of Surgery, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322192DOI Listing
June 2011

Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP).

Lab Chip 2011 Mar 7;11(6):1118-25. Epub 2011 Feb 7.

School of Mechanical Engineering, Yonsei University, 262 Seongsan-no Seodaemun-gu, Seoul, 120-749, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c0lc00345jDOI Listing
March 2011

US surveillance of regional lymph node recurrence after breast cancer surgery.

Radiology 2009 Sep 22;252(3):673-81. Epub 2009 Jun 22.

Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2523081977DOI Listing
September 2009

Sonographic surveillance for the detection of contralateral metachronous breast cancer in an Asian population.

AJR Am J Roentgenol 2009 Jan;192(1):221-8

Department of Radiology, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, Seoul 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.07.4048DOI Listing
January 2009

Role of sonography in the detection of contralateral metachronous breast cancer in an Asian population.

AJR Am J Roentgenol 2008 Feb;190(2):476-80

Department of Diagnostic Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, Seoul 120-752, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.07.2683DOI Listing
February 2008